K2M Group (KTWO) Earns News Impact Score of 0.34
News stories about K2M Group (NASDAQ:KTWO) have been trending positive on Sunday, according to Accern. The research firm identifies positive and negative news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. K2M Group earned a daily sentiment score of 0.34 on Accern’s scale. Accern also assigned media coverage about the medical device company an impact score of 47.2140888555871 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Here are some of the news headlines that may have impacted Accern Sentiment Analysis’s rankings:
- K2M Group Holdings Inc (KTWO) Expected to Announce Quarterly Sales of $65.85 Million (americanbankingnews.com)
- K2M Launches Next-Generation YUKON™ OCT Spinal System at AANS/CNS 2018 (finance.yahoo.com)
- -$0.22 EPS Expected for K2M Group Holdings Inc (KTWO) This Quarter (americanbankingnews.com)
- K2M Group (KTWO) Upgraded at BidaskClub (americanbankingnews.com)
Several research analysts have weighed in on KTWO shares. Needham & Company LLC upped their price objective on shares of K2M Group from $20.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, January 9th. BidaskClub upgraded shares of K2M Group from a “hold” rating to a “buy” rating in a research note on Wednesday, January 10th. Wells Fargo lowered shares of K2M Group from an “outperform” rating to a “market perform” rating and set a $23.00 price objective on the stock. in a research note on Monday, December 4th. Zacks Investment Research upgraded shares of K2M Group from a “sell” rating to a “hold” rating in a research note on Thursday, January 25th. Finally, Oppenheimer set a $24.00 price objective on shares of K2M Group and gave the company a “buy” rating in a research note on Thursday, March 1st. One analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $24.50.
K2M Group (NASDAQ:KTWO) last announced its quarterly earnings results on Wednesday, February 28th. The medical device company reported ($0.20) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.19) by ($0.01). K2M Group had a negative return on equity of 14.85% and a negative net margin of 14.40%. The business had revenue of $67.80 million for the quarter, compared to analyst estimates of $67.36 million. During the same quarter last year, the company earned ($0.30) EPS. The business’s revenue for the quarter was up 9.7% compared to the same quarter last year. sell-side analysts expect that K2M Group will post -0.72 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “K2M Group (KTWO) Earns News Impact Score of 0.34” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.watchlistnews.com/k2m-group-ktwo-earns-news-impact-score-of-0-34/1942158.html.
K2M Group Company Profile
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.
Receive News & Ratings for K2M Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group and related companies with MarketBeat.com's FREE daily email newsletter.